GlassScriptPrepare for your visit
Joel Schor
Bluefield, WV · NPI 1003866997
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$8,436.14
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- E.R. Squibb & Sons, L.L.C. $870.98
- Novartis Pharmaceuticals Corporation $869.46
- Janssen Biotech, INC. $857.75
- Merck Sharp & Dohme LLC $594.29
- Astrazeneca Pharmaceuticals LP $557.82
- Pfizer INC. $425.47
Questions you might ask
- I saw Joel Schor listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/181770/joel-schor